✉news BusinessStartups first seen 22 h ago, last 18 h ago, peak #37
Italian biotech Aptadir raises €40M seed round for RNA inhibitors
Original: Italian newco Aptadir raises €40M seed round for RNA inhibitors
Aptadir, a newly formed Italian biotech company, has raised a €40 million seed round to develop RNA inhibitors. The funding marks one of the larger seed rounds for an Italian life sciences startup and will support early-stage development of the company's RNA-targeting therapeutic platform as it builds out its research operations.
Why now: Large seed financing for a new Italian biotech is notable news for Europe's startup and life sciences community.
Rank over time, top of the chart is #1. 2 snapshots from 22 h ago to 18 h ago.
Evidence
- Italian newco Aptadir raises €40M seed round for RNA inhibitors · BioWorld News
API: https://socialmediatrends-api.osmike.com/v1/trends/412837